Controversies with the diagnosis and management of HELLP syndrome

Clinical Obstetrics and Gynecology

Volumn 48, Issue 2, 2005, Pages 460-477

  O'Brien, John M ^a   Barton, John R ^a  

^a CENTRAL BAPTIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID; MAGNESIUM SULFATE; VASODILATOR AGENT;

BED REST; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DEATH; DELIVERY; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; HELLP SYNDROME; HEMATOMA; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; LIVER NECROSIS; LIVER PARENCHYMA; MATERNAL MORBIDITY; PLASMA VOLUME; PREECLAMPSIA; PREGNANCY COMPLICATION; REVIEW; SIDE EFFECT; STEROID THERAPY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADRENAL CORTEX HORMONES; COUNSELING; DELIVERY, OBSTETRIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HELLP SYNDROME; HEMATOMA; HUMANS; LIVER DISEASES; POSTPARTUM PERIOD; PREGNANCY; RUPTURE;

EID: 18044374090     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000160309.73197.35     Document Type: Review

References (49)

1. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
2. Pritchard JA, Weisman R, Ratnoff OD, et al. Intravascular hemolysis, thrombocytopenia and other hemologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954;250:89-98.
3. Chesley LC. Disseminated intravascular coagulation. In: Hypertensive Disorders in Pregnancy. New York: Appleton-Century-Crofts; 1978:88-118.
4. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142: 159-167.
5. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001; 357:53-56.
6. Roberts JM. Preeclampsia, what we know and what we do not know. Semin Perinatol. 2000;24:24-28.
7. Barton JR, Riely CA, Adamel TA, et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol. 1992;167:1538-1543.
8. Aarnoudse JG, Houthoff HF, Weits J, et al. A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy. A clinical and histopathological study. Br J Obstet Gynaecol. 1986;93: 145-155.
9. Arias F, Mancilla-Jimenez R. Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. N Engl J Med. 1976;295: 578-582.
10. Barton JR, Sibai BM. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol. 1996;174:1820-1827.
11. Sibai BM, Taslimi MM, El-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155:501-509.
12. Martin JN Jr, Rinehart B, May WL, et al. The spectrum of severe preeclampsia: Comparative analysis by HELLP syndrome classification. Am J Obstet Gynecol. 1999;180:1373-1384.
13. VanPampus MG, Wolf H, Westenberg SM, et al. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with preeclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol. 1998;76:31-36.
14. Visser W, Wallenburg HCS. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol. 1995;102:111-117.
15. Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol. 1999;180:221-225.
16. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162:311-316.
17. Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes and thrombocytopenia. Obstet Gynecol. 1985; 66:657-660.
18. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169: 1000-1006.
19. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181-192.
20. Clark SL, Phelan JR, Allen SH, et al. Antepartum reversal of hematologic abnormalities associated with the HELLP syndrome. J Reprod Med. 1987;32:781-784.
21. Magann EF, Bass D, Chauhan SP, et al. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol. 1994;171:1148-1153.
22. Magann EE, Perry KG Jr, Meydrech EF, et al. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol. 1994;171: 1154-1158.
23. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol. 1999; 181:304-309.
24. O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol. 2000;183: 921-924.
25. Vigil-DeGracia P, Garcia-Caceres E. Dexamethasone in the postpartum treatment of HELLP syndrome. Int J Gynaecol Obstet. 1997;59:217-221.
26. Yalcin OT, Sener T, Hassa H, et al. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet. 1998;61:141-148.
27. Isler CM, Barrilleaux PS, Magann EF, et al. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP syndrome. Am J Obstet Gynecol. 2001;184:1332-1339.
28. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103:981-991.
29. O'Brien JM, Shumate SA, Satchwell SL, et al. Maternal benefit to corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol. 2002;186: 475-479.
30. Martin JN Jr, Thigpen BD, Rose CH, et al. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol. 2003;189: 830-834.
31. Bush K, O'Brien JM, Milligan DA, et al. The utility of umbilical artery Doppler in women with the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 2001;184:1087-1089.
32. Briggs R, Chari RS, Mercer B, et al. Post-operative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): does delayed primary closure make a difference? Am JObstet Gynecol. 1996;175:893-896.
33. Chelmow D, Rodriguez EJ, Sabatini MM. Suture closure of subcutaneous fat and wound disruption after cesarean delivery: a meta-analysis. Obstet Gynecol. 2004; 103:974-980.
34. Goodlin RC, Anderson JC, Hodgson PE. Conservative treatment of liver hematoma in the postpartum period. J Reprod Med. 1985;30:368-370.
35. Manas KJ, Welsh JD, Rankin RA, et al. Hepatic hemorrhage without rupture in preeclampsia. N Engl J Med. 1985;312: 424-426.
36. Neerhof MG, Zelman W, Sullivan T. Hepatic rupture in pregnancy: a review. Obstet Gynecol Surv. 1989;44:407-409.
37. Sibai BM, Mabie BC, Harvey CJ. Pulmonary edema in severe preeclampsia-eclampsia: analysis of 37 consecutive cases. Am J Obstet Gynecol. 1987;156:1174-1179.
38. Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol. 1993;168:1682-1687.
39. Smith LG Jr, Moise KJ Jr, Dildy GA, et al. Spontaneous rupture of the liver during pregnancy: current therapy. Obstet Gynecol. 1991;77:171-175.
40. Loevinger EH, Lee WM, Anderson MC. Hepatic rupture associated with pregnancy: treatment with transcatheter embolotherapy. Obstet Gynecol. 1985;65: 281-284.
41. Martin JN Jr, Perry KG, Blake PG, et al. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol. 1997;177:1011-1017.
42. Martin JN Jr, Files JC, Blake PG, et al. Plasma exchange for preeclampsia: I. Postpartum use for persistently severe preeclampsia-eclampsia with HELLP syndrome. Am J Obstet Gynecol. 1990;162:126-137.
43. Martin JN Jr, Files JC, Blake PG, et al. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP syndrome. Am J Obstet Gynecol. 1995;172:1107-1127.
44. Schwartz ML. Possible role for exchange plasmapheresis with fresh frozen plasma for maternal indications in selected cases of preeclampsia and eclampsia. Obstet Gynecol. 1986;68:136-139.
45. Sibai BM, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172:125-129.
46. Van Pampus MG, Wolf H, Mayrahu G, et al. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy. 2001;20:15-23.
47. Chames MC, Haddad B, Barton JR, et al. Subsequent pregnancy outcome in women with a history of HELLP syndrome at ≤28 weeks of gestation. Am J Obstet Gynecol. 2003;188:1504-1508.
48. Knapen M, VanAltena A, Peters WHM, et al. Liver function following pregnancy complicated by the HELLP syndrome. Br J Obstet Gynaecol. 1998;105:1208-1210.
49. Jacquemyn Y, Jochems L, Duiker E, et al. Long-term renal function after HELLP syndrome. Gynecol Obstet Invest. 2004;57: 117-120.